-
Join 34 other subscribers
Categories
Top Posts
Blogroll
Author Archives: Alexander Szewczak
Boston edges out Cambridge for new technology firms
In a somewhat surprising development, Boston actually had more venture capital deals than Cambridge in 2013. Ninety-seven deals were signed in Boston, vs. 78 in Cambridge. Cambridge does still hold a commanding lead in the dollar amount, however, with total funding … Continue reading
Peter Drucker on Outsourcing and Information Technology
I stumbled on a 2004 interview of Peter Drucker, one of the giants of management consulting and education. Drucker was famous for coining the term “knowledge worker”, and he was an early proponent of outsourcing (starting decades ago). It’s worth reading the interview in its … Continue reading
Spectacular Night Sky as Winter Turns to Spring
As Winter turned to Spring here in Eastern Massachusetts, tonight’s sky was spectacular (the image above is a fairly good approximation). At about 9 o’clock facing West, there was an amazing view of Orion looming in the middle of the sky, … Continue reading
Moore’s Law for Space-Based Imaging
Hundreds of eyes in the sky, just like this one. Getting better, cheaper, and more numerous every year. Imagine a network of satellites, all taking daily pictures of the earth beneath them and reporting that data back to earth in … Continue reading
Posted in Innovation, Space & Astronomy
Tagged Disruptive innovation, Planet Labs, Satellite imaging, Silicon Valley
Leave a comment
More Biotech Hub Rankings
GEN (Genetic Engineering and Biotechnology News) has released their own, more comprehensive biotech hub rankings. As expected, Boston-Cambridge and the Bay Area are at the top, with San Francisco edging out Boston in most criteria. The GEN rankings include not only … Continue reading
Posted in Biotech, Innovation, Research
Tagged Biomedical Research, Biotech cluster, Boston, San Francisco
Leave a comment
Venture Funding of Biotech is VERY Concentrated… and Very Limited
Fierce Biotech has released their latest analysis of venture capital funding of biotech in the U.S. last year, broken down by metropolitan area: Source: http://www.fiercebiotech.com/story/top-15-cities-biotech-venture-funding/2014-03-06 San Francisco is back out in front, edging out Boston-Cambridge. After San Diego and Washington, funding … Continue reading
Posted in Biotech, Innovation, Research
Tagged Biomedical Research, Biotech, Boston, Cambridge, Pharmaceutical industry, San Francsico, Venture capital
Leave a comment
Employee Performance Does Not Follow a Bell Curve
Here’s a great post written by Josh Bersin that’s gotten a lot of attention in the past few days: The Myth of the Bell Curve. As I mentioned several weeks ago, more and more evidence shows that employee performance in the … Continue reading
Posted in Fixing Big Pharma Research, Management
Tagged bell curve, Performance management
3 Comments
P values. I do not think that value means what you think it means.
Regina Nuzzo has a news feature in Nature about P values that every biomedical scientist should read. P values — the common measure of statistical significance (i.e. the “believability” of an experiment) — do not mean what most scientists think they mean. … Continue reading
Posted in Data Analysis
Tagged P-values, scientific reproducibility, statistical confidence
Leave a comment
MechanizedIntelligence 